Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Patients that maintained treatment response for 2 weeks at the end of the open label treatment period were eligible to be randomized to ongoing treatment with the same dose of VYVANSE (N=78) or switched to placebo (N=79) during the double-blind phase
We prioritize personalized care and encourage patients to discuss their individual circumstances with our healthcare professionals
.png)
GPX4: Glutathione peroxidase 4
Second, track your results objectively
US$ 25.99
US$ 24.64
US$ 25.59
.png.jpg)
US$ 24.99
US$ 23.79
US$ 25.10
